|

Pilot Study Evaluating the Impact of Stress Reduction on Atherosclerotic : Heart and Mind Study

RECRUITINGN/ASponsored by Massachusetts General Hospital
Actively Recruiting
PhaseN/A
SponsorMassachusetts General Hospital
Started2018-09-01
Est. completion2026-01-31
Eligibility
Age30 Years – 65 Years
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT04496947

Summary

The plot study aims to evaluate the effect of 8 weeks of stress reducing intervention on atherosclerotic plaque inflammation in adults, as quantified by positron emission tomography (PET) with fluorine-2-deoxy-D-glucose (FDG) in individuals with increased psychosocial stress.

Eligibility

Age: 30 Years – 65 YearsHealthy volunteers accepted
Inclusion Criteria:

* • Aged between 30-65 years

  * Identifies as having increased levels of stress and/or has a Perceived Stress Scale (PSS) score \>5 at baseline, and is interested in participating

Exclusion Criteria:

* Perceived Stress Scale (PSS) score \<6

Conditions4

AtherosclerosisHeart DiseaseInflammationStress

Locations1 site

Massachusetts General Hospital
Boston, Massachusetts, 02114
Ahmed Tawakol, MD6177243699atawakol@mgh.harvard.edu

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.